These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 12647087)

  • 1. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [No indication for thrombophilia screening in patients with idiopathic venous thromboembolism and their relatives].
    Middeldorp S; Prins MH; Büller HR
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1047-51. PubMed ID: 11414164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
    Wåhlander K; Eriksson H; Lundström T; Billing Clason S; Wall U; Nyström P; Wessman P; Schulman S;
    Br J Haematol; 2006 Apr; 133(1):68-77. PubMed ID: 16512831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of thrombophilia.
    García de Frutos P
    Thromb Haemost; 2007 Sep; 98(3):485-7. PubMed ID: 17849035
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thrombophilia in deciding on the duration of anticoagulation.
    Bauer KA
    Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilia and venous thromboembolism: implications for testing.
    Cohn DM; Roshani S; Middeldorp S
    Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombophilic states: their relevance in prevention and treatment of venous thromboembolism].
    Poul H; Kessler P
    Vnitr Lek; 2009 Mar; 55(3):242-52. PubMed ID: 19378855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombophilic conditions in the pathogenesis of venous thromboembolism].
    Poul H
    Vnitr Lek; 2006 Mar; 52 Suppl 1():17-25. PubMed ID: 16637445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
    Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
    Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited thrombophilia and venous thromboembolism.
    Simioni P; Tormene D; Spiezia L; Tognin G; Rossetto V; Radu C; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The optimum length of anticoagulation therapy after venous thromboembolism--universal or individualised approach?].
    Hirmerová J
    Vnitr Lek; 2007 Jun; 53(6):662-8. PubMed ID: 17702126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of screening on thrombophilia for patients with venous thrombosis.
    Paschôa AF; Guillaumon AT
    Int Angiol; 2006 Mar; 25(1):52-9. PubMed ID: 16520725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should be tested for thrombophilia?
    Simioni P
    Curr Opin Hematol; 2006 Sep; 13(5):337-43. PubMed ID: 16888438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.